Insights

Innovative Cell Therapy Focus Adicet Bio specializes in allogeneic gamma-delta T cell therapies targeting both autoimmune diseases and cancer, representing a cutting-edge and emerging segment within the biotech industry. This positions the company as a potential partner for healthcare providers and research institutions seeking advanced immunotherapy solutions.

Recent Strategic Collaborations The company's partnership with MaxCyte for developing off-the-shelf T-cell therapies highlights their focus on scalable, readily available treatment options. This creates sales opportunities with biotech firms and clinical organizations interested in off-the-shelf cellular products for broader patient access.

Pipeline and Regulatory Milestones Adicet has received FDA Fast Track Designation for ADI-001 in systemic sclerosis and is testing therapies across multiple autoimmune indications, indicating a robust product development pipeline and regulatory recognition. This suggests potential opportunities to engage with the company during clinical milestones and product launches.

Financial Strength and Funding With funding of over $384 million and current revenues between 50 and 100 million dollars, Adicet Bio demonstrates substantial financial backing and growth potential, making it a viable partner or customer for contract manufacturing, research collaborations, and strategic investments.

Market and Industry Position As a clinical-stage biotech competing with firms like Allogene and bluebird bio, Adicet’s focus on autoimmune and oncological therapies within a fast-growing cell therapy market presents significant sales opportunities in research alliances, clinical trial support, and early adoption of innovative therapeutic solutions.

Adicet Bio, Inc Tech Stack

Adicet Bio, Inc uses 8 technology products and services including GDPR, OneTrust, LinkedIn Learning, and more. Explore Adicet Bio, Inc's tech stack below.

  • GDPR
    Certificates
  • OneTrust
    Cookie Compliance
  • LinkedIn Learning
    Learning Management System
  • Linux
    Programming Languages
  • HSTS
    Security
  • Adobe Tag Manager
    Tag Management
  • Acquia Cloud Site Factory
    Web Hosting
  • Apache
    Web Servers

Media & News

Adicet Bio, Inc's Email Address Formats

Adicet Bio, Inc uses at least 1 format(s):
Adicet Bio, Inc Email FormatsExamplePercentage
FLast@adicetbio.comJDoe@adicetbio.com
91%
FirstLast@adicetbio.comJohnDoe@adicetbio.com
5%
Last_First@adicetbio.comDoe_John@adicetbio.com
3%
LastF@adicetbio.comDoeJ@adicetbio.com
1%

Frequently Asked Questions

Where is Adicet Bio, Inc's headquarters located?

Minus sign iconPlus sign icon
Adicet Bio, Inc's main headquarters is located at 1000 Bridge Pkwy, Redwood City, California 94065, US. The company has employees across 3 continents, including North AmericaAsiaAfrica.

What is Adicet Bio, Inc's phone number?

Minus sign iconPlus sign icon
You can contact Adicet Bio, Inc's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Adicet Bio, Inc's stock symbol?

Minus sign iconPlus sign icon
Adicet Bio, Inc is a publicly traded company; the company's stock symbol is ACET.

What is Adicet Bio, Inc's official website and social media links?

Minus sign iconPlus sign icon
Adicet Bio, Inc's official website is adicetbio.com and has social profiles on LinkedInCrunchbase.

What is Adicet Bio, Inc's SIC code NAICS code?

Minus sign iconPlus sign icon
Adicet Bio, Inc's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Adicet Bio, Inc have currently?

Minus sign iconPlus sign icon
As of October 2025, Adicet Bio, Inc has approximately 138 employees across 3 continents, including North AmericaAsiaAfrica. Key team members include Chief Financial Officer: N. H.Chief Technology Officer: D. H.Vp Of Translational Medicine: F. D.. Explore Adicet Bio, Inc's employee directory with LeadIQ.

What industry does Adicet Bio, Inc belong to?

Minus sign iconPlus sign icon
Adicet Bio, Inc operates in the Biotechnology Research industry.

What technology does Adicet Bio, Inc use?

Minus sign iconPlus sign icon
Adicet Bio, Inc's tech stack includes GDPROneTrustLinkedIn LearningLinuxHSTSAdobe Tag ManagerAcquia Cloud Site FactoryApache.

What is Adicet Bio, Inc's email format?

Minus sign iconPlus sign icon
Adicet Bio, Inc's email format typically follows the pattern of FLast@adicetbio.com. Find more Adicet Bio, Inc email formats with LeadIQ.

How much funding has Adicet Bio, Inc raised to date?

Minus sign iconPlus sign icon
As of October 2025, Adicet Bio, Inc has raised $384M in funding. The last funding round occurred on Dec 01, 2021 for $101M.

Adicet Bio, Inc

Biotechnology ResearchUnited States51-200 Employees

At Adicet (Nasdaq: ACET), we are defined by our mission to deliver best-in-class gamma-delta T cell therapies for patients fighting autoimmune diseases and cancer. Every one of our team members, whether in the lab, manufacturing, or general business role, comes to work every day with the patient in mind. 

As pioneers in the cell therapy space, we are honored and humbled by the opportunity to put our talents to bear in developing transformative therapies to defeat autoimmune diseases and cancer. We believe that the best way to do this is through discovering and developing allogeneic gamma-delta T cell therapies, a novel type of cell therapy.

Adicet has chosen the gamma-delta T cell because it:
•	Preferentially traffics to tissues and provides B cell depletion, potentially leading to an immune reset for patients with autoimmune diseases.
•	Has multiple ways to target and kill cancer cells including solid tumors. 

We also chose to use cells from donors (allogeneic) to enable our potential therapies to be readily available when needed (taken “off-the-shelf” or available to the patient on demand). 

We’re not just blazing new trails in cell therapy, we’re having fun along the way. With regular team gatherings, many shared meals, larger company events, and a consistent commitment to our values, we have a strong culture! 

We are proud to attract and retain some of the greatest talent in the biopharma and cell therapy space, and we’re consistently giving back to our employees. The Adicet benefits package includes generous financial compensation, comprehensive health plans, generous paid time-off, educational reimbursement, and access to many amenities in our state-of-the-art facility. 

To learn more or inquire about joining our team in Boston, MA or Redwood City, CA, please visit http://www.adicetbio.com

Section iconCompany Overview

Headquarters
1000 Bridge Pkwy, Redwood City, California 94065, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ACET
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $384M

    Adicet Bio, Inc has raised a total of $384M of funding over 4 rounds. Their latest funding round was raised on Dec 01, 2021 in the amount of $101Mas a initial public offering.

  • $50M$100M

    Adicet Bio, Inc's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $384M

    Adicet Bio, Inc has raised a total of $384M of funding over 4 rounds. Their latest funding round was raised on Dec 01, 2021 in the amount of $101Mas a initial public offering.

  • $50M$100M

    Adicet Bio, Inc's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.